{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:12:44Z","timestamp":1784027564061,"version":"3.55.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Our objective was to maintain low interlaboratory variation and bias in international normalized ratio (INR) results following a network change in instrumentation and reagents, using a process of ongoing standardization and harmonization.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Network-wide standardization to new common instrument and reagent platforms followed by network-wide application of a simple novel process of verification of international sensitive index and mean normal prothrombin time values for each new lot of prothrombin time (PT) reagent that does not require use of World Health Organization reference thromboplastin or INR calibration\/certified plasma.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The network transitioned from mechanical hemostasis detection instruments with associated PT reagent (Diagnostica Stago; NeoPTimal) to optical detection (ACL TOPs) with associated PT reagent (Werfen; RecombiPlasTin 2G). Comparing 3 years of data for each situation, the network (n = 27 laboratories) maintained low INR variability and bias relative to general mechanical and optical groups and other laboratories.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Harmonized support for patient management of vitamin K antagonists such as warfarin was continuously maintained in our geography, with potentially positive implications for other coagulation laboratories and geographies. For the United States in particular, paucity of US Food and Drug Administration\u2013cleared INR certified plasmas potentially compromises INR test accuracy; our novel approach may provide workable alternatives for other laboratories\/networks.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajcp\/aqae090","type":"journal-article","created":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T05:49:14Z","timestamp":1719035354000},"page":"28-41","source":"Crossref","is-referenced-by-count":11,"title":["Continued harmonization of the international normalized ratio across a large laboratory network: Evidence of sustained low interlaboratory variation and bias after a change in instrumentation"],"prefix":"10.1093","volume":"163","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2103-1661","authenticated-orcid":false,"given":"Emmanuel J","family":"Favaloro","sequence":"first","affiliation":[{"name":"Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Sydney Centres for Thrombosis and Haemostasis, NSW Health Pathology, Westmead Hospital , Westmead, New South Wales ,","place":["Australia"]},{"name":"School of Dentistry and Medical Sciences, Faculty of Science and Health, Charles Sturt University , Wagga Wagga, New South Wales ,","place":["Australia"]},{"name":"School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Westmead Hospital , Westmead, New South Wales ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandya","family":"Arunachalam","sequence":"additional","affiliation":[{"name":"RCPAQAP Haematology , St Leonards, New South Wales ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Chapman","sequence":"additional","affiliation":[{"name":"Department of Haematology, NSW Health Pathology, John Hunter Hospital , Newcastle, New South Wales ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8237-6743","authenticated-orcid":false,"given":"Leonardo","family":"Pasalic","sequence":"additional","affiliation":[{"name":"Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Sydney Centres for Thrombosis and Haemostasis, NSW Health Pathology, Westmead Hospital , Westmead, New South Wales ,","place":["Australia"]},{"name":"Westmead Clinical School, University of Sydney , Westmead, New South Wales ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,18]]},"reference":[{"issue":"8","key":"2025012906064089600_CIT0001","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1055\/s-0034-1395160","article-title":"From vitamin K antagonists to liver international normalized ratio: a historical journey and critical perspective","volume":"40","author":"Gatt","year":"2014","journal-title":"Semin Thromb Hemost."},{"issue":"2","key":"2025012906064089600_CIT0002","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1055\/s-0035-1544231","article-title":"Pros and cons of vitamin K antagonists and non\u2013vitamin K antagonist oral anticoagulants","volume":"41","author":"Riva","year":"2015","journal-title":"Semin Thromb Hemost."},{"issue":"2","key":"2025012906064089600_CIT0003","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1055\/s-0035-1544159","article-title":"The new or non\u2013vitamin K antagonist oral anticoagulants: what have we learned since their debut","volume":"41","author":"McMahon","year":"2015","journal-title":"Semin Thromb Hemost."},{"issue":"2","key":"2025012906064089600_CIT0004","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1136\/heartjnl-2022-321387","article-title":"Antithrombotic therapy after heart valve intervention: review of mechanisms, evidence and current guidance","volume":"110","author":"Cheng","year":"2023","journal-title":"Heart."},{"issue":"15","key":"2025012906064089600_CIT0005","doi-asserted-by":"publisher","first-page":"4984","DOI":"10.3390\/jcm12154984","article-title":"DOACs in the anticoagulation of mechanical valves: a systematic review and future perspectives","volume":"12","author":"Langenaeken","year":"2023","journal-title":"J Clin Med."},{"issue":"SI","key":"2025012906064089600_CIT0006","doi-asserted-by":"publisher","first-page":"SI96","DOI":"10.1093\/rheumatology\/kead538","article-title":"Anticoagulant and non-anticoagulant therapy in thrombotic antiphospholipid syndrome: old drugs and new treatment targets","volume":"63","author":"Ruiz-Irastorza","year":"2024","journal-title":"Rheumatology (Oxford)."},{"issue":"11","key":"2025012906064089600_CIT0007","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1177\/09612033221118463","article-title":"Direct oral anticoagulants versus warfarin in patients with antiphospholipid syndrome: a meta-analysis of randomized controlled trials","volume":"31","author":"Lee","year":"2022","journal-title":"Lupus."},{"issue":"5","key":"2025012906064089600_CIT0008","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1515\/CCLM.2009.140","article-title":"Pharmacogenetics of vitamin K antagonists: useful or hype","volume":"47","author":"Lippi","year":"2009","journal-title":"Clin Chem Lab Med."},{"issue":"2 Suppl","key":"2025012906064089600_CIT0009","first-page":"e44S","volume":"141","author":"Ageno","year":"2012","journal-title":"Oral Anticoagulant Therapy Antithrombotic Therapy and Prevention of Thrombosis."},{"issue":"1","key":"2025012906064089600_CIT0010","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1055\/s-0038-1667342","article-title":"How to generate a more accurate laboratory-based international normalized ratio: solutions to obtaining or verifying the mean normal prothrombin time and international sensitivity index","volume":"45","author":"Favaloro","year":"2019","journal-title":"Semin Thromb Hemost."},{"issue":"2","key":"2025012906064089600_CIT0011","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1055\/s-0035-1544156","article-title":"Comparative efficacy and safety of the non\u2013vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation","volume":"41","author":"Senoo","year":"2015","journal-title":"Semin Thromb Hemost."},{"issue":"5","key":"2025012906064089600_CIT0012","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/CIRCOUTCOMES.114.000804","article-title":"Improving quality measurement for anticoagulation: adding international normalized ratio variability to percent time in therapeutic range","volume":"7","author":"Razouki","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes."},{"issue":"3","key":"2025012906064089600_CIT0013","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1055\/s-0035-1549091","article-title":"International normalized ratio monitoring of vitamin K antagonist therapy: comparative performance of point-of-care and laboratory-derived testing","volume":"41","author":"Bonar","year":"2015","journal-title":"Semin Thromb Hemost."},{"issue":"11","key":"2025012906064089600_CIT0014","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.5858\/2007-131-1641-LROTIN","article-title":"Laboratory reporting of the international normalized ratio: progress and problems","volume":"131","author":"Olson","year":"2007","journal-title":"Arch Pathol Lab Med."},{"issue":"3","key":"2025012906064089600_CIT0015","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1055\/s-0035-1544197","article-title":"Bridging the gap between point-of-care testing and laboratory testing in hemostasis","volume":"41","author":"Kitchen","year":"2015","journal-title":"Semin Thromb Hemost."},{"issue":"5","key":"2025012906064089600_CIT0016","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.jtha.2023.01.038","article-title":"Laboratory international normalized ratios determined with commercial thromboplastins in &gt;450 centers before and after the establishment of the International Standard for human thromboplastin-rTF 16: data from United Kingdom National External Quality Assessment Scheme for Blood Coagulation","volume":"21","author":"Kitchen","year":"2023","journal-title":"J Thromb Haemost."},{"issue":"3","key":"2025012906064089600_CIT0017","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1515\/cclm-2022-1080","article-title":"Using three external quality assurance schemes to achieve equivalent international normalized ratio results in primary and secondary healthcare","volume":"61","author":"Stavelin","year":"2022","journal-title":"Clin Chem Lab Med."},{"issue":"2","key":"2025012906064089600_CIT0018","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.thromres.2016.12.007","article-title":"Explaining and reducing the variation in inter-laboratory reported values for international normalised ratio","volume":"150","author":"Bonar","year":"2017","journal-title":"Thromb Res."},{"key":"2025012906064089600_CIT0019","volume-title":"Procedures for Validation of INR and Local Calibration of PT\/INR Systems; Approved Guideline. H54-A, Vol. 25, No. 23.","year":"2005"},{"key":"2025012906064089600_CIT0020","volume-title":"Requirements for Thromboplastins and Plasma Used to Control oral Anticoagulant Therapy (Requirements for Biological Substances no. 30, Revised 1982). WHO Expert Committee on Biological Standardization.","year":"1983"},{"issue":"3","key":"2025012906064089600_CIT0021","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-0038-1657371","article-title":"Calibration of reference thromboplastins and standardisation of the prothrombin time ratio","volume":"49","author":"Kirkwood","year":"1983","journal-title":"Thromb Haemost."},{"issue":"4","key":"2025012906064089600_CIT0022","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.jtha.2023.12.013","article-title":"Defining a metrologically traceable and sustainable calibration hierarchy of international normalized ratio for monitoring of vitamin K antagonist treatment in accordance with International Organization for Standardization (ISO) 17511:2020 standard: communication from the International Federation of Clinical Chemistry and Laboratory Medicine-SSC\/ISTH working group on prothrombin time\/international normalized ratio standardization","volume":"22","author":"van den Besselaar","year":"2024","journal-title":"J Thromb Haemost."},{"key":"2025012906064089600_CIT0023","author":"FDA 510(k) Premarket Notification database"},{"issue":"3","key":"2025012906064089600_CIT0024","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/00313020801911454","article-title":"Time to think outside the box? Prothrombin time (PT), international normalised ratio (INR), international sensitivity index (ISI), mean normal prothrombin time (MNPT) and measurement of uncertainty (MU): a novel approach to standardisation","volume":"40","author":"Favaloro","year":"2008","journal-title":"Pathology (Phila)."},{"issue":"6","key":"2025012906064089600_CIT0025","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.pathol.2017.04.011","article-title":"Replacing warfarin therapy with the newer direct oral anticoagulants, or simply a growth in anticoagulation therapy? implications for pathology testing","volume":"49","author":"Favaloro","year":"2017","journal-title":"Pathology (Phila)."},{"issue":"8","key":"2025012906064089600_CIT0026","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1515\/CCLM.2010.216","article-title":"Improving the harmonization of the international normalised ratio (INR): time to think outside the box","volume":"48","author":"Favaloro","year":"2010","journal-title":"Clin Chem Lab Med."},{"issue":"1","key":"2025012906064089600_CIT0027","doi-asserted-by":"crossref","first-page":"13","DOI":"10.29074\/ascls.25.1.13","article-title":"Improving the inter-laboratory harmonization of the international normalized ratio (INR): utilizing the concept of transference to estimate and\/or validate international sensitivity index (ISI) and mean normal prothrombin time (MNPT) values and\/or to eliminate measurement bias","volume":"25","author":"Favaloro","year":"2012","journal-title":"Clin Lab Sci."},{"issue":"2","key":"2025012906064089600_CIT0028","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/ajcp\/aqv022","article-title":"Harmonizing the international normalized ratio (INR): standardization of methods and use of novel strategies to reduce interlaboratory variation and bias","volume":"145","author":"Favaloro","year":"2016","journal-title":"Am J Clin Pathol."},{"key":"2025012906064089600_CIT0029","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/978-1-0716-3175-1_5","article-title":"Harmonization of hemostasis testing across a large laboratory network: an example from Australia","volume":"2663","author":"Favaloro","year":"2023","journal-title":"Methods Mol Biol."},{"issue":"4","key":"2025012906064089600_CIT0030","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/ajcp\/aqab004","article-title":"Verification of the ACL Top 50 family (350, 550 and 750) for harmonization of routine coagulation assays in a large network of 60 laboratories","volume":"156","author":"Favaloro","year":"2021","journal-title":"Am J Clin Pathol."},{"key":"2025012906064089600_CIT0031","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-1-4939-7196-1_4","article-title":"Optimizing the verification of mean normal prothrombin time (MNPT) and international sensitivity index (ISI) for accurate conversion of prothrombin time (PT) to international normalized ratio (INR)","volume":"1646","author":"Favaloro","year":"2017","journal-title":"Methods Mol Biol."},{"issue":"1","key":"2025012906064089600_CIT0032","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/ijlh.13349","article-title":"Standardization of prothrombin time\/international normalized ratio (PT\/INR)","volume":"43","author":"Dorgalaleh","year":"2021","journal-title":"Int J Lab Hematol."},{"issue":"1","key":"2025012906064089600_CIT0033","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1055\/s-0033-1363475","article-title":"Local verification and assignment of mean normal prothrombin time and international sensitivity index values across various instruments: recent experience and outcome from North America","volume":"40","author":"Tange","year":"2014","journal-title":"Semin Thromb Hemost."},{"issue":"4","key":"2025012906064089600_CIT0034","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.pathol.2017.11.090","article-title":"Mathematical rounding as a post-analytical issue in pathology reporting: generation of bias in INR resulting","volume":"50","author":"Favaloro","year":"2018","journal-title":"Pathology (Phila)."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/163\/1\/28\/58590557\/aqae090.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/163\/1\/28\/58590557\/aqae090.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T06:06:50Z","timestamp":1738130810000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/163\/1\/28\/7716605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,7,18]]},"published-print":{"date-parts":[[2025,1,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqae090","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,7,18]]}}}